Table 4 Effect of the intervention on lymphocyte subset percentages.

From: Evaluation of the benefits of neutral bicarbonate ionized water baths in an open-label, randomized, crossover trial

 

Control (n = 25), mean (± SD)

NBIW (n = 25), mean (± SD)

Between-group comparison (4 weeks)

Within-group comparison

p

d or r

Effect size

p

Control

NBIW

CD3+

%

Baseline

73.936 ± 6.476

0.3633

0.09

0.0044**

0.0834

Week 4

72.460 ± 6.052

72.998 ± 6.561

CD4 + 

%

Baseline

51.861 ± 7.358

0.0395*

0.22

Small

0.0076**

0.6514

Week 4

50.025 ± 6.382

51.563 ± 7.453

CD4+CD45RA+

%

Baseline

43.172 ± 11.520

0.1166

− 0.14

0.9746

0.0062**

Week 4

43.142 ± 12.323

41.448 ± 11.545

CD8+

%

Baseline

12.326 ± 5.408

0.1815

− 0.17

0.0065**

0.8746

Week 4

13.382 ± 5.743

12.416 ± 5.927

CD8+CD28+

%

Baseline

73.261 ± 12.081

0.7982

− 0.04

0.2641

0.4926

Week 4

72.256 ± 13.544

72.314 ± 12.797

CD16+CD56

%

Baseline

0.719 ± 0.431

0.1424

− 0.21

Small

0.1935

0.0017**

Week 4

0.587 ± 0.405

0.500 ± 0.355

CD16CD56+

%

Baseline

4.456 ± 3.128

0.8823

− 0.02

0.7672

0.3817

Week 4

4.570 ± 3.418

4.477 ± 2.966

CD16+CD56+

%

Baseline

7.868 ± 3.198

0.3958

− 0.16

0.2406

0.7995

Week 4

8.472 ± 2.885

8.008 ± 2.993

CD20+

%

Baseline

15.623 ± 4.726

0.8625

− 0.01

0.0366*

0.0222*

Week 4

16.698 ± 5.421

16.630 ± 5.203

  1. Distribution of CD3+, CD4+, CD4+CD45RA+, CD8+, CD16+CD56+, and CD20+ populations was parametric, and distribution of other populations was non-parametric.
  2. Between-group and within-group comparisons were tested by a paired t test (for parametric data) and Wilcoxon signed-rank test (for non-parametric data).
  3. *p < 0.05, **p < 0.01.
  4. For parametric data, effect size was calculated as Cohen’s d: small (0.2 ≤|d|< 0.5), medium (0.5 ≤|d|< 0.8), large (0.8 ≤|d|); for non-parametric data, effect size was calculated as r family: small (0.1 ≤|r|< 0.3), medium (0.3 ≤|r|< 0.5), large (0.5 ≤|r|).
  5. NBIW, neutral bicarbonate ionized water.